# Larimar Therapeutics, Inc.: Form SC 13D/A, filed Mar 15, 2024

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: SC 13D/A
- Filed: 2024-03-15
- Accepted by EDGAR: Mar 15, 2024, 16:37 ET
- Period: not reported
- Accession: 0001193805-24-000378
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119380524000378/e619370_sc13da-lt.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119380524000378/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119380524000378/e619370_sc13da-lt.htm

Filed Mar 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001193805-24-000378. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
